Online BusinessDr Reddy's forays into transdermal patch segment
Hyderabad-based pharmaceutical major, Dr Reddy’s Laboratories, forayed into the transdermal patch segment with the launch of Finrid – a medicated adhesive patch used in the management of severe to moderate pain – in the Indian market.
Sensex ends up 35pts
The scrip of Dr Reddy’s is currently trading at Rs 815 on the BSE, up 0.11 per cent as against the previous close of Rs 814.10.